Performance of Currently Available traNscaTHEter Aortic Valve Platforms in Inoperable Patients With Pure Aortic regurgitatiON of a Native Valve. The PANTHEON International Project.

N/AUnknownNCT05319171

IRCCS Policlinico S. Donato100 enrolled

Overview

* To investigate the performance of currently available THVs in terms of safety and efficacy * To evaluate potential predictors of THV embolization or migration (TVEM) * To assess the impact of TVEM on prognosis

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Aortic Regurgitation

Interventions

TAVRDEVICE

TAVR

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * severe aortic regurgitation * prohibitive surgical risk Exclusion Criteria: * surgical candidates

Locations (1)

IRCCS Policlinico S. Donato, Milan, Italy

Milan, Milan, Italy

Outcomes

Primary Outcomes

Overall mortality

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.